Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
JKN2304 in Moderate to Severe COPD
NCT07450482Phase 2Completed
- Sponsor
- Joincare Pharmaceutical
- Start
- Jul 2025
- Primary completion
- Sep 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of JKN2304 in chronic obstructive pulmonary disease (COPD), sponsored by Joincare Pharmaceutical. Started Jul 2025; status: completed.
02
Drugs
JKN2304
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT07450482.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07450482.